Scientific notes

Immune Check Point Modulator in Cancer Therapy

Immune Checkpoint Modulators

Summary

 Immune Checkpoint modulators are new promising therapies that specifically target the ability of tumors to become “invisible” to the patient immune systems. Several proteins are involved in this mechanism, the below video will highlight the main ones and their role in the immune response

Discover our Check Point modulator validation system — Save biopsies, improve result quality and reduce false positive and negative

Related Posts

Diagram of a triple-negative breast cancer cell showing absence of ER, PR, and HER2 receptors, representing the defining features of TNBC and its lack of conventional therapeutic targets.
Triple-Negative Breast Cancer and the Application of Breast Cance...
Triple-negative breast cancer (TNBC) is a distinct pathological subtype defined by the absence of estrogen receptor (ER), progesterone recep...
Read more
cherry-biotech_breast_cancer_tumor_microenvironment
3D Breast Cancer Microenvironment: From Organoids to Organ‑onâ€...
Introduction Following our articles on how breast cancer organoids and breast‑cancer‑on‑chip platforms expand beyond conventional 2D...
Read more
Summary_TME-e1547732632185
Tumor microenvironment (TME)...
The tumor microenvironment (TME) is a complex biochemical network that includes multiple factors surrounding tumor cells, such as vascular n...
Read more

get in touch

Get the best insights about Cherry Biotech by Email Let’s stay in touch!
As part of our commercial prospecting, we may need to process your personal data. For more information, please consult our Privacy Policy